Patent · US Active

Biaryl kinase inhibitors

US9902722B2 · kind B2 · utility

12Cited by

0References

13Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Guanglin Luo · Newtown, US
Ling Chen · Shanghai, CN
Carolyn Diane Dzierba · Middletown, US
Jonathan L. Ditta · Meriden, US
John E. Macor · Guilford, US
Joanne J. Bronson · Madison, US

Key dates

Filing date	Apr 1, 2015
Grant date	Feb 27, 2018
Priority date	—
Expiry date	Apr 1, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.